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Abstract 
Background: The aim of this study was to assess whether echocardiographic measurements of left 
atrial (LA) morphology and function could predict sinus rhythm maintenance after electrical cardiover-
sion among patients with atrial fibrillation (AF) and normal function or mild dysfunction of the left 
ventricle (LV). 
Methods: One hundred seventeen patients with persistent AF who underwent successful electrical 
cardioversion were prospectively enrolled. Echocardiography was performed one day  subsequent to suc-
cessful cardioversion. Patients were followed up clinically and electrocardiographically at 1, 6, and 12 
months. At 12 months, 61 (52%) patients had maintained sinus rhythm (SR).  
Results: Compared to patients who maintained SR, those with AF recurrence had larger LAs, worse 
LA systolic function, and increased LV filling pressure. On multivariate stepwise logistic regression, 
E/A ratios (odds ratio [OR] 0.550, 95% confidence interval [CI] 0.341–0.886; p = 0.014) and E/e’ 
ratios (OR 0.871, 95% CI 0.771–0.985; p = 0.027) were significant predictors of AF recurrence. On 
receiver operator characteristic curve analysis of AF recurrence at 12 months, the area under curve for 
both E/A and E/e’ ratios were 0.726. With an E/A cutoff of 2.2, the sensitivity for predicting AF recur-
rence at 12 months was 72%, and specificity was 73%. With an E/e’ cutoff of 9.17, the sensitivity for 
predicting AF recurrence at 12 months was 72%, and specificity was 74%. 
Conclusions: Left ventricular filling pressure assessed with E/A and E/e’ ratios predict AF recurrence 
after electrical cardioversions among patients with AF and normal function of LV.  (Cardiol J XXXX; 
XX, X: xx–xx)
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Introduction 
Atrial fibrillation (AF) is the most common 
arrhythmia, and it is caused by structural, mechani-
cal, and electrical remodeling of the atria, including 
atrial enlargement, fibrosis, and dysfunction of ion 
channels [1–3]. Management of AF is aimed at 
restoration and maintenance of sinus rhythm (SR) 
or control of the ventricular rate [4]. In the Euro 
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was about 75–88%, depending on the cardioversion 
method and patient characteristics. In the same 
registry, about 70% of patients maintained SR for 
12 months [5]. AF recurs in many patients after 
successful cardioversion, and this recurrence is 
associated with different clinical, electrocardio-
graphic, echocardiographic, imaging, and laboratory 
factors [2, 6–9]. Risk factors for recurrence of AF 
can help select patients in whom cardioversion can 
restore SR in the long-term. Moreover, patients 
with a very high risk of AF recurrence could avoid 
the risk of cardioversion. Under investigation, in 
this study, was whether assessing left atrial (LA) 
morphology and function by echocardiography 
could help predict the recurrence of AF after elec-
trical cardioversion. 
Methods 
The study protocol was approved by the lo-
cal ethics committee. This prospective study 
enrolled 117 patients with persistent AF who 
underwent direct current cardioversion between 
August 2015 and April 2017 on a cardiology ward. 
The inclusion criteria were as follows: sympto-
matic persistent AF for ≥ 7 days, ejection fraction 
> 40%, and effective anticoagulation with warfarin, 
acenocumarol, or novel oral anticoagulants (dabi-
gatran, rivaroxaban, apixaban) for ≥ 3 weeks prior 
to cardioversion. The exclusion criteria were as 
follows: age < 18 years, no consent to participate in 
the study, no consent for cardioversion, low quality 
of echocardiographic images, moderate or severe 
valve regurgitation or stenosis, valvular prosthesis, 
presence of thrombus in the left atrial appendage 
(LAA), acute decompensation of heart failure, 
acute myocardial infarction, previous pulmonary 
vein isolation, dysthyroidism, anemia (hemoglobin 
< 6.9 mmol/L), and cancer.
Patients were followed up at 1, 6, and 12 
months to check for maintenance of SR (electrocar-
diogram on each visit and 24-h Holter monitoring at 
1 and 12 months). Patients were asked to report to 
the cardiology department if they felt palpitations 
or thought that AF had recurred.
Clinical data were obtained on the day of 
cardioversion and included age, sex, body mass 
index (BMI), body surface area (BSA, calculated 
with the Gehan and George formula), glomerular 
filtration rate (GFR, calculated with the Cockroft-
Gault formula), hypertension, diabetes mellitus, 
dyslipidemia, smoking status, history of coronary 
artery disease, European Heart Rhythm Asso-
ciation (EHRA) score, dysthyroidism, obstructive 
pulmonary disease, renal disease, and history 
of stroke or transient ischemic attack. Coronary 
artery disease was diagnosed when patients had 
a history of myocardial infarction, percutaneous 
coronary intervention, or coronary artery by-pass 
grafting. Data regarding AF duration and duration 
of the current AF episode is not taken into ac-
count because of the high percentage of patients 
who were unable to ascertain the onset of ar-
rhythmias. CHA2DS2-VASc and HAS-BLED scores 
were recorded according to the current European 
guidelines on AF treatment [4].
All cardioversions were performed with an-
aesthesiologic assistance under general sedation. 
All cardioversions were performed with a biphasic 
defibrillator (150–300 J). If the first shock was 
ineffective, another attempt was performed with 
a higher energy (by 100 J). The success of car-
dioversion was defined as SR maintenance for 
≥ 24 h. Patients with SR received anticoagulants, 
up-stream therapy, or antiarrhythmic drugs by 
clinical judgment. Antiarrhythmic drugs, like 
amiodarone and propafenone, were prescribed by 
a physician blinded to echocardiography results.
Echocardiography was performed on the day 
after successful cardioversion, during SR. One 
experienced investigator performed transthoracic 
echocardiography with the Vivid S6 device (Gen-
eral Electric Medical Systems, Horten, Norway) 
and the M4S RS transducer, according to current 
guidelines [10, 11]. Standard M-mode and Doppler 
images and 2-dimentional cine loops were obtained 
in the parasternal long and short axis views and 
apical 2-, 3-, and 4-chamber views. Echocardio-
graphic data were stored and analysed offline with 
the EchoPAC PC software (GE Medical Systems). 
The maximal end-systolic volume of left atrium 
(LAV) and minimal end-diastolic volume (LAEDV) 
were measured by the Simpson method from api-
cal 4- and 2-chamber views. Maximum volume 
of LA (LAV) was measured at the end of systole, 
on the frame just before mitral valve opening, by 
tracing the inner border of the atrium and avoid-
ing the area under the valve annulus, appendage, 
and pulmonary veins. LAV was indexed to body 
surface area (BSA, LAVI). Minimum volume of LA 
was measured at the end of ventricular diastole 
on the frame of the mitral valve closure, and was 
indexed to BSA (LAEDVI). LA emptying fraction 
(LA EF) was calculated with the following formula: 
(LA maximum volume – LA minimum volume)/LA 
maximum volume × 100%. Left ventricular (LV) 
volume and ejection fraction (LVEF) were meas-
ured according to the Simpson formula. The area 
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of right atrium at systole (RAAs) was measured in 
an apical 4-chamber view at the end of the systole, 
and the right atrium area at the diastole (RAAd) 
was measured at the end of the diastole on the 
frame with the tricuspid valve closure. Blood flow 
velocities were measured by transmitral pulsed 
wave Doppler (PWD) from the apical 4-chamber 
view, with a 2-mm sample volume placed between 
the tips of the mitral leaflets. Mitral annulus motion 
was measured by tissue Doppler imaging (TDI) in 
an apical 4-chamber view with a 5-mm sample vol-
ume at the lateral and septal basal regions. Means 
of waves s’, e’, and a’ were calculated as averages 
from the septal and lateral measurements. 
Statistical analysis
Results are presented as means ± standard de-
viations (SD). Categorical variables are presented 
as counts and percentages. Normally distributed 
variables were compared with the Student t-test, 
and non-normally distributed variables were com-
pared with the Mann-Whitney test or c2 test.
Predictors of SR maintenance were analyzed 
with univariate logistic regression. To identify 
independent predictors of AF recurrence, a multi-
variable model that included independent variables 
with p value of < 0.1 found in univariate analysis 
and adjusted by important cofactors that might have 
an influence on outcomes was performed. The step-
wise inclusion was set at p < 0.05 and exclusion at 
p > 0.1. Receiver-operated characteristic (ROC) 
curves for predicting SR maintenance at 1, 6, and 
12 months were calculated for selected echocardio-
graphic variables. Optimal cutoffs were calculated 
based on the Youden statistic, and areas under the 
curve (AUC) were compared with the DeLong test 
with the AUC that indicated no diagnostic values 
(0.5). Significance was set at p < 0.05.  Statistical 
analyses were performed with MedCalc Statistical 
Software version 18.6 (MedCalc Software bvba, 
Ostend, Belgium). 
Results
One hundred seventeen patients who un-
derwent successful electrical cardioversion were 
included in the study. Of these patients, 56 (47.8%) 
maintained SR at 12 months. Compared with pa-
tients with AF recurrence, patients who maintained 
SR at 12 months were younger (p = 0.027), were 
more often male (p = 0.024), had diabetes mellitus 
more often (p = 0.047), had higher GFR values 
(p = 0.043), used beta-blockers more often before 
and after cardioversion (p ≤ 0.030), and used diuret-
ics less often before and after cardioversion (p ≤ 
0.010). There were no other significant differences 
in baseline characteristics between patients who 
maintained SR over 12 months and the remaining 
patients (Table 1).  
Nearly all patients had LA enlargement, with a 
mean LAVI of 49.7 ± 11.4 mL/m2 and low or mod-
erate LA enlargement in the antero-posterior di-
mension (44.5 ± 4.7 mm). Compared with patients 
with AF recurrence, patients who maintained SR at 
12 months had significantly lower values of LAVI 
(p = 0.001) and LAEDVI (p < 0.001). 
Compared with patients with AF recurrence, 
patients who maintained SR at 12 months had 
a significantly higher LA EF (p < 0.001), atrial 
filling wave A (p = 0.033), and late diastolic mitral 
annular velocity (wave a’, p = 0.041). 
Compared with patients with AF recurrence, 
patients who maintained SR at 12 months had sig-
nificantly lower E/e’ ratios (p < 0.001), E/A ratios 
(p < 0.001), and early filling velocities (wave E, 
p < 0.001), and they had significantly higher 
early diastolic mitral annular velocities (wave  e, 
p = 0.008) and deceleration times of wave E (DT, 
p = 0.003). 
Patients with AF recurrence and patients who 
maintained SR at 12 months did not differ significant-
ly with respect to LV function. However, patients 
who maintained SR at 12 months tended to have 
higher values of mitral annular peak systolic velocity 
(wave s’, p = 0.051). Table 2 presents values for all 
echocardiographic variables. 
On univariate logistic regression, the follow-
ing echocardiographic variables were significant 
predictors of SR maintenance at 12 months: LAVI, 
LAEDVI, LA EF, waves s’, e’, and E, E/e’ and E/A 
ratios, and DT (Table 3). On multivariate stepwise, 
forward, and backward logistic regression, only 
E/e’ and E/A ratios remained significant predictors 
of SR maintenance. In ROC curve analysis, both 
E/e’ and E/A ratios had a similar value for predict-
ing SR maintenance at 1, 6, and 12 months, with 
AUCs of about 0.7 and sensitivity, specificity, and 
predictive values of about 70–75% (Figs. 1 and 2, 
Table 4). In ROC curve analysis of E/e’ and E/A 
for predicting SR maintenance at 12 months of 
observation AUC of E/e’ was 0,726 (95% confidence 
interval [CI] 0.630–0.822) and E/A was 0.726 (95% 
CI 0.632–0.821).  
Discussion 
In this study, it was shown that LV filling pres-
sure and atrial enlargement were significant predic-
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tors of SR maintenance after electrical cardiover-
sion in patients with AF. Moreover, parameters of 
LV filling pressure were independent predictors of 
AF recurrence.
Although electrical cardioversion is effective 
in most patients with AF, high rates of AF recur-
rence are observed regardless of anti-arrhythmic 
therapy used. The current study investigated the 
relationship between echocardiographic param-
eters and AF recurrence after electrical cardiover-
sion among patients with normal function of LV. 
Also in the present study, about  half of the patients 
maintained SR over 12 months after a successful 
electrical cardioversion, which is similar to the 
figure from the Euro Heart Survey registry (61%) 
[5]. A slightly higher rate in the Euro Heart Survey 
could be because this registry included patients 
with first detected, paroxysmal, and persistent AF. 
Table 1. Baseline characteristics.
Study population;  
n = 117
SR maintenance;  
n = 61 (52%)
No SR maintenance;  
n = 56 (47.8%)
P
Age [years] 65 ± 10.4 62.984 ± 11.5593 67.196 ± 8.6811 0.027
Age < 65 years 48 (41%) 29 (47.5%) 19 (33.9%) 0.137
Age 65–74 years 51 (43.6%) 24 (39.3%) 27 (48.2%) 0.336
Age ≥ 75 years 18 (15.4%) 9 (14.8%) 9 (16.1%) 0.844
Male 73 (62.4%) 44 (72.1%) 29 (51.8%) 0.024
Body mass index [kg/m²] 30.9±7.7 31.6±9.4 30.1±5.3 0.324
Hypertension 98 (83.8%) 50 (82%) 48 (85.7%) 0.585
Diabetes mellitus 22 (18.8%) 13 (21.3%) 9 (16.1%) 0.047
Coronary artery disease 18 (15.5%) 10 (16.4%) 8 (14.5%) 0.785
EHRA III–IV 38 (32.5%) 21 (34.4%) 17 (30.4%) 0.640
Stroke/TIA 10 (8.5%) 5 (8.2%) 5 (8.9%) 0.888
Vascular disease 13 (11.1%) 8 (13.1%) 5 (8.9%) 0.474
CHA2DS2-VASC 2.7 ± 1.5 2.6 ± 1.5 2.8 ± 1.6 0.230
CHA2DS2-VASC = 0 7 (6%) 3 (4.9%) 4 (7.1%) 0.614
CHA2DS2-VASC =1 22 (18.8%) 14 (23%) 8 (14.3%) 0.233
CHA2DS2-VASC ≥ 2 88 (75.2%) 44 (72.1%) 44 (78.6%) 0.422
HAS-BLED 0.7 ± 0.6 0.8 ± 0.5 0.9 ± 0.4 0.566
Smokers 7 (6%) 4 (6.6%) 3 (5.4%) 0.785
GFR [mL/min] 85.6 ± 31.1 91 ± 30 79.6 ± 31.4 0.043
Beta-blockers pre 107 (92.2%) 59 (98.3%) 48 (85.7%) 0.012
Amiodarone pre 13 (11.1%) 6 (9.8%) 7 (12.5%) 0.648
ACEI/ARB pre 99 (84.6%) 51 (83.6%) 48 (85.7%) 0.753
Statins pre 74 (63.8%) 42 (70%) 32 (57.1%) 0.152
Diuretics pre 48 (42.1%) 18 (30.5%) 30 (54.5%) 0.009
Spironolactone/ 
/eplerenone pre
25 (22.1%) 16 (27.1%) 9 (16.7%) 0.183
Beta-blockers post 91 (79.1%) 53 (86.9%) 38 (70.4%) 0.030
Amiodarone post 37 (32.2%) 19 (31.1%) 18 (33.3%) 0.803
Propafenone post 37 (32.2%) 20 (32.8%) 17 (31.5%) 0.882
ACEI/ARB post 99 (84.6%) 52 (85.2%) 47 (83.9%) 0.844
Statins post 73 (63.5%) 40 (65.6%) 33 (61.1%) 0.621
Diuretics post 49 (43%) 19 (31.7%) 30 (55.6%) 0.010
Spironolactone/ 
/eplerenone post
28 (25%) 17 (28.3%) 11 (21.2%) 0.384
ACEI — angiotensin converting enzyme inhibitors; ARB — angiotensin II receptor blockers; EHRA — European Heart Rhythm Association;  
GFR — glomerular filtration rate; pre — before cardioversion; post — after cardioversion; SR — sinus rhythm; TIA — transient ischemic attack
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Table 2. Echocardiographic variables.
Study population,  
n = 117
SR maintenance,  
n = 61 (52%)
No SR maintenance,  
n = 56 (47.8%)
P
RV prox [mm] 31.2 ± 3.8 31.7 ± 4.1 30.6 ± 3.5 0.224
IVS [mm] 10.8 ± 1.8 10.6 ± 1.7 11.1 ± 1.8 0.229
LVEDD [mm] 51.4 ± 6.5 51.9 ± 6.6 50.8 ± 6.4 0.351
LVESD [mm] 36 ± 7.8 36.8 ± 8.2 35.2 ± 7.4 0.292
LVEDV [mL] 133.8 ± 39.4 138.2 ± 38.6 128.7 ± 40 0.192
LVESV [mL] 56.2 ± 25 58.6 ± 26.6 53.7 ± 23.1 0.435
LVSV [mL] 77.6 ± 23.2 80.2 ± 21.5 74.8 ± 24.8 0.213
EF [%] 59.3 ± 9.6 59.2 ± 9.9 59.4 ± 9.4 0.896
LA AP [mm] 44.5 ± 4.7 44 ± 4.1 44.9 ± 5.2 0.281
LAVI [mL/m2] 49.7 ± 11.4 46.6 ± 10.4 53.1 ± 11.5 0.001
LAEDV index [mL/m2] 32.5 ± 11.2 28.8 ± 9.3 36.5 ± 11.7 < 0.001
LA EF [%] 35.9 ± 10.6 39 ± 8.4 32.5 ± 11.7 < 0.001
RAA s [cm2] 22.8 ± 5 22.5 ± 5.3 23.1 ± 4.6 0.517
RAA d [cm2] 15.7 ± 3.9 15.9 ± 3.9 15.6 ± 3.9 0.799
s’ mean [cm/s] 6.5 ± 1.8 6.8 ± 1.9 6.2 ± 1.6 0.051
e’ mean [cm/s] 9.4 ± 2.3 10 ± 2.3 8.8 ± 2.1 0.008
a’ mean [cm/s] 5.1 ± 2.2 5.4 ± 2.1 4.8 ± 2.2 0.041
E/e’ mean 10.3 ± 4 9 ± 3.5 11.8 ± 4.1 < 0.001
E [m/s] 0.9 ± 0.2 0.9 ± 0.2 1 ± 0.2 < 0.001
A [m/s] 0.4 ± 0.2 0.5 ± 0.2 0.4 ± 0.2 0.033
E/A 2.4 ± 1.1 2 ± 0.8 2.9 ± 1.3 < 0.001
DT [ms] 183.4 ± 42.7 193.9 ± 42.9 171.7 ± 39.6 0.003
SR — sinus rhythm; RV prox — right ventricular proximal diameter; IVS — interventricular septum wall thickness; LVEDD — left ventricular 
end-diastolic diameter; LVESD — left ventricular end-systolic diameter; LVEDV — left ventricular end-diastolic volume; LVESV — left ventricular 
end-systolic volume; LVSV — left ventricular stroke volume; EF — ejection fraction; LAAP — left atrium anteroposterior diameter; LAVI — 
end-systolic volume of left atrium indexed to body surface area; LAEDV — minimal end-diastolic volume; LA EF — emptying fraction of left 
atrium; RAA — right atrium area; d — diastolic; s — systolic; DT — deceleration times of wave E
Table 3. Echocardiographic predictors of sinus rhythm maintenance at 12 months.
Univariate analysis Multivariable stepwise analysis 
OR 95% CI P OR 95% CI P
LAVI [mL/m2] 0.946 0.912–0.982 0.003
LAEDVI [mL/m2] 0.928 0.891–0.968 < 0.001
LA EF [%] 1.066 1.025–1.109 0.002
s’ mean [cm/s] 1.252 1.003–1.564 0.047
e’ mean [cm/s] 1.258 1.057–1.497 0.010
E [m/s] 0.056 0.008–0.389 0.004
A [m/s] 10.402 0.995–108.754 0.051
E/e’ mean 0.815 0.724–0.916 0.001 0.871 0.771–0.985 0.027
E/A 0.421 0.266–0.667 < 0.001 0.550 0.341–0.886 0.014
DT [ms] 1.014 1.004–1.024 0.007
CI — confidence interval; OR — odds ratio; LAVI — end-systolic volume of left atrium indexed to body surface area; LAEDVI — minimal end-
diastolic volume indexed to body surface area; LA EF — left atrium emptying fraction; DT — deceleration times of wave E
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In the current study, nearly all measures of LA 
size and systolic function and LV filling pressure 
were significant predictors of SR maintenance, this 
is in line with previous studies [2, 6–9, 12–19]. 
Importantly, it was found that echocardiographic 
measures of LV filling pressure were independent 
predictors of AF recurrence after electrical cardiover-
sion. Similarly, several previous studies showed that 
E/e’ ratios or E/A ratios were independent predictors 
of AF recurrences after cardioversion or pulmonary 
vain isolation [6, 14, 16, 17]. Although both E/e’ and 
E/A ratios are measures of LV filling pressure, E/A 
values are more likely affected by loading status 
and thus depend on preload. In our study, E/A ratios 
predicted AF recurrence slightly better than E/e’ 
(a higher odds ratio, but similar AUCs).
In the present study, patients regardless of 
LA size we included. Chung et al. [14] reported 
that E/e’ ratios and LAVI were predictors of AF 
recurrence over 40 months in patients after phar-
macological or electrical cardioversion, excluding 
patients with LA dimension > 50 mm [14]. Thus, 
LV filling pressure may be a predictor of AF even 
in patients with no visible structural remodeling. 
In the study by Chung et al. [14], an optimal E/e’ 
cutoff for predicting AF recurrence (9.15) was 
very similar to that of the current study, with 
a similar sensitivity and specificity (75% and 73.1%, 
respectively). Those investigators did not analyse 
E/A ratios. 
In another study, among 127 patients with LA 
enlargement and LAVI ≥ 34 mL/m2, AF recurred 
Figure 1. Prediction of sinus rhythm maintenance at 1, 6, 
and 12 months. Receiver operating characteristic curves 
for E/e’ ratios. P values for AUC comparisons with no 
effect (AUC = 0.5, DeLong test); AUC — area under the 
curve; M — month.
Figure 2. Prediction of sinus rhythm maintenance at 
1, 6, and 12 months. Receiver operating characteristic 
curves for E/A ratios. P values for comparisons with no 
diagnostic vale (AUC = 0.5, DeLong test); AUC — area 
under the curve; M — month.
Table 4. Receiver operating curve analysis of E/A and E/e’ ratios as predictors of sinus rhythm maintenance 
12 months after electrical cardioversion.
Variable AUC Cutoff* Sensitivity (%) Specificity (%) PPV (%) NPV (%)
E/A 0.726 ≤ 2.2 72.13 73.21 74.6 70.7
E/e’ 0.726 ≤ 9.17 72.1 74.1 75.9 70.2
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in 29% patients over 3 months [6]. In that study, 
septal E/e’ ratios calculated during SR were the 
best predictor of AF recurrence after electrical 
cardioversion, with a cutoff ≥ 11 better than ≥ 
8. In those patients with LA enlargement, LAVI 
was not a significant predictor of AF recurrence. 
Similarly, in another study, non-indexed LA volume 
and LA anteroposterior dimension did not differ 
between patients with maintenance of SR and AF 
recurrence [15].
Similar to our findings, Kosiuk et al. [17] 
showed that E/A ratios were an independent risk 
factor for AF recurrence within 1 week after pul-
monary vein isolation, but not 3–12 months after 
the procedure. Supposedly, E/A ratios can predict 
AF recurrence only shortly after pulmonary vein 
isolation because atrial haemodynamic function 
may be reduced transiently after this procedure.
Most studies on the predictors of SR main-
tenance after cardioversion have concentrated on 
LV and LA. However, Luong et al. [13] showed 
that the emptying fraction of RA predicted SR 
after electrical cardioversion better than did the 
emptying fraction of LA. Moreover, in another 
study, these investigators showed that RAVI was 
a better predictor of sinus rhythm maintenance 
after electrical cardioversion than LAVI [18]. In 
contrast, RA area was not a significant predictor 
of SR maintenance in our study.  
Our study was carried out in one centre and 
involved a small sample. However, our study is one 
of the largest studies to date on echocardiographic 
predictors of SR maintenance after electrical car-
dioversion of AF. When interpreting our results, 
one should remember that echocardiography is 
operator-dependent and requires experience and 
skill. Therefore, in our study, all echocardiographic 
measurements were taken by one experienced in-
vestigator. We carried out echocardiography after 
successful cardioversion during SR. Our current 
work is concentrated on finding echocardiographic 
predictors of SR maintenance that could be meas-
ured before cardioversion, i.e., during AF. In our 
study, we did not measure RA EF, which could be 
a predictor of SR maintenance after electrical cardi-
oversion of AF. In this study, we did not analyse AF 
duration because we were not able to ascertain it 
reliably. AF is often asymptomatic or its symptoms 
can develop slowly [20, 21]. Many of our patients 
were unable tell when AF started. Lastly, heart 
rhythm monitoring was limited to a 24-h Holter, at 
months 1 and 12, and a 12-lead electrocardiogram 
at the remaining follow-up visits. 
Conclusions
Increased LV filling pressure assessed with 
E/A and E/e’ ratios may be an important risk factor 
for AF recurrence after successful electrical car-
dioversion. These findings are in line with previous 
research showing that increased filling pressure 
(septal E/e’ ratios) is an independent predictor of 
mortality [19]. Our findings may help predict SR 
maintenance after electrical cardioversion, but fur-
ther studies should investigate whether reducing 
E/A or E/e’ ratios could improve the outcomes of 
electrical cardioversions or ablation among patients 
with AF.  
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